1,913
Views
0
CrossRef citations to date
0
Altmetric
Research Papers

Patients’ perspectives of collagenase injection or needle fasciotomy and rehabilitation for Dupuytren disease, including hand function and occupational performance

ORCID Icon & ORCID Icon
Pages 986-996 | Received 16 Sep 2021, Accepted 19 Feb 2022, Published online: 09 Mar 2022

References

  • Hindocha S. Risk factors, disease associations, and dupuytren diathesis. Hand Clin. 2018;34(3):307–314.
  • Gudmundsson K, Arngrı́msson R, Sigfússon N, et al. Epidemiology of dupuytren’s disease: clinical, serological, and social assessment. The reykjavik study. J Clin Epidem. 2000;53(3):291–296.
  • Shih B, Bayat A. Scientific understanding and clinical management of dupuytren disease. Nat Rev Rheumatol. 2010;6(12):715–726.
  • Lanting R, Broekstra D, Werker P, et al. A systematic review and Meta-Analysis on the prevalence of dupuytren disease in the general population of Western countries. Plast Reconstr Surg. 2014;133(3):593–603.
  • Bergenudd H, Lindgärde F, Nilsson B. Prevalence of dupuytren’s contracture and its correlation with degenerative changes in the hand and feet and with criteria of general health. J Hand Surg. 1993;18(2):254–257.
  • Engstrand C, Borén L, Liedberg G. Evaluation of activity limitation and digital extension in Dupuytren's contracture three months after fasciectomy and hand therapy interventions. J Hand Ther. 2009;22(1):21–27.
  • Pratt A, Byrne G. The lived experience of Dupuytren's disease of the hand . J Clin Nurs. 2009;18(12):1793–1802.
  • Engstrand C, Krevers B, Kvist J. Factors affecting functional recovery after surgery and hand therapy in patients with dupuytren's disease. J Hand Ther. 2015;28(3):255–260.
  • Turesson C, Kvist J, Krevers B. Experiences of men living with dupuytren’s disease – consequences of the disease for hand function and daily activities. J Hand Ther. 2020;33:386–393.
  • Wilburn J, McKenn SP, Perry-Hinsley D, et al. The impact of dupuytren disease on patient activity and quality of life. J Hand Surg Am. 2013;38(6):1209–1214.
  • Badalamente A, Hurst L. Development of collagenase treatment for dupuytren disease. Hand Clin. 2018;34(3):345–349.
  • Desai S, Hentz V. The treatment of dupuytren disease. J Hand Surg Am. 2011;36(5):936–942.
  • Haase S, Chung K. Bringing it all Together: A Practical Approach to the Treatment of Dupuytren Disease. Hand Clin. 2018;34(3):427–436.
  • Werker P, Pess G, van Rijssen A, et al. Correction of contracture and recurrence rates of dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am. 2012;37(10):2095–2105.
  • Sanjuan - Cerveró V. Efficacy of collagenase Clostridium Histolyticum for dupuytren disease: a systematic review. Revista Iberoamericana de Cirugía de La Mano. 2017;45(2):70–88.
  • Buckwalter V, Kitchin S, Goldfarb C, et al. Needle aponeurotomy versus collagenase injections for dupuytren disease: a review of the literature and survey of Patient-Reported satisfaction, recurrence, and complications after needle aponeurotomy. J Hand Surg Global Online. 2019;1(2):91–95.
  • Sweet S, Blackmore S. Surgical and therapy update on the management of Dupuytren's disease. J Hand Ther. 2014;27(2):77–84.
  • Turesson C. The role of hand therapy in dupuytren disease. Hand Clin. 2018;34(3):395–401.
  • Ball C, Pratt A, Nanchahal J. Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice. BMC Musculoskelet Disord. 2013;14(1):131.
  • Becker G, Davis T. The outcome of surgical treatments for primary Dupuytren's disease-a systematic review. J Hand Surg Eur Vol. 2010;35(8):623–626.
  • Chen N, Srinivasan R, Shauver M, et al. A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture. Hand (N Y)). 2011;6(3):250–255.
  • Rodrigues J, Becker G, Ball C, Cochrane Musculoskeletal Group, et al. Surgery for dupuytren’s contracture of the fingers. The. Cochrane Database of Systematic Reviews. 2015;2015(12):CD010143–CD010143.
  • Rodrigues J, Zhang W, Scammell B, et al. Recovery, responsiveness and interpretability of patient-reported outcome measures after surgery for Dupuytren's disease. J Hand Surg Eur Vol. 2017;42(3):301–309.
  • Thoma A, Kaur M, Ignacy T, et al. Psychometric properties of Health-Related quality of life instruments in patients undergoing palmar fasciectomy for dupuytren's disease: a prospective study. Hand (N Y)). 2014;9(2):166–174.
  • Karpinski M, Moltaji S, Baxter C, et al. A systematic review identifying outcomes and outcome measures in Dupuytren's disease research. J Hand Surg Eur Vol. 2020;45(5):513–520.
  • Turesson C, Kvist J, Krevers B. Patients' needs during a surgical intervention process for Dupuytren's disease . Disabil Rehabil. 2019;41(6):666–673.
  • Poelstra R, Selles R, Slijper H, Hand-Wrist Study Group, et al. Better patients' treatment experiences are associated with better postoperative results in Dupuytren's disease. J Hand Surg Eur Vol. 2018;43(8):848–854.
  • Takata W, Wade E, Roll S. Hand therapy interventions, outcomes, and diagnoses evaluated over the last 10 years: a mapping review linking research to practice. J Hand Ther. 2019;32(1):1–9.
  • Strömberg J, Ibsen-Sörensen A, Fridén J. Comparison of treatment outcome after collagenase and needle fasciotomy for Dupuytren Contracture: a randomized, single-blinded, clinical trial with a 1-year follow-up. J Hand Surg Am. 2016;41(9):873–880.
  • Elzinga K, Morhart M. Needle aponeurotomy for dupuytren disease. Hand Clin. 2018;34(3):331–344.
  • Krefter C, Marks M, Hensler S, et al. Complications after treating Dupuytren's disease. A systematic literature review. Hand Surg Rehabil. 2017;36(5):322–329.
  • Aglen T, Matre K, Lind C, et al. Hand therapy or not following collagenase treatment for Dupuytren's contracture? Protocol for a randomised controlled trial. BMC Musculoskelet Disord. 2019;20(1):314–387.
  • Krippendorf K. Content analysis. An introduction to its methodology. 3rd ed. Thousand Oaks (CA): Sage;2013.
  • Krevers N, Närvänen A-L, Oberg B. Patient evaluation of the care and rehabilitation process in geriatric hospital care. Disabil Rehabil. 2002;24(9):482–491.
  • Engstrand C, Kvist J, Krevers B. Patients' perspective on surgical intervention for dupuytren's disease - experiences, expectations and appraisal of results. Disabil Rehabil. 2016;38(26):2538–2549.
  • Tufford L, Newman P. Bracketing in qualitative research. Qualitative Social Work. 2012;11(1):80–96.
  • Patton MQ. Qualitative research & evaluation methods. 3rd ed. Thousand Oaks (CA): Sage; 2002.
  • Hermanns H. Interviewing as an activity. In: Flick U, Kardorff E, Steinke I, eds. A companion to qualitative research. London: SAGE; 2004. 209–213.
  • Lincoln YS, Guba EG. But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation. In: Williams D, Editor new directions for program evaluation. San Francisco: Jossey-Bass: 1986. 73–84.
  • Korstjens I, Moser A. Series: practical guidance to qualitative research. Part 4: trustworthiness and publishing. Eur J Gen Pract. 2018;24(1):120–124.
  • Bradley J, Warwick D. Patient satisfaction with collagenase. J Hand Surg Am. 2016;41(6):689–697.
  • Hentz V. Collagenase injections for treatment of dupuytren disease. Hand Clin. 2014;30(1):25–32.
  • Warwick D, Arner M, Pajardi G, POINT X Investigators, et al. Collagenase clostridium histolyticum in patients with dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes. J Hand Surg Eur Vol. 2015;40(2):124–132.
  • Witthaut J, Jones G, Skrepnik N, et al. Efficacy and safety of collagenase clostridium histolyticum injection for dupuytren contracture: short-term results from 2 open-label studies. J Hand Surg Am. 2013;38(1):2–11.
  • Marks M, Herren D, Vliet Vlieland T, et al. Determinants of patient satisfaction after orthopedic interventions to the hand: a review of the literature. J Hand Ther. 2011;24(4):303–312.
  • Smith-Forbes EV, Howell DM, Willoughby J, et al. Adherence of individuals in upper extremity rehabilitation: a qualitative study. Arch Phys Med Rehabil. 2016;97(8):1262–1268.e1.
  • Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences;fewer data on costs. Health Aff (Millwood)). 2013;32(2):207–214.
  • Gruber JS, Hageman M, Neuhaus V, et al. Patient activation and disability in upper extremity illness. J Hand Surg Am. 2014;39(7):1378–1383.
  • Groth GN, Wulf MB. Compliance with hand rehabilitation. Health beliefs and strategies. J Hand Therapy. 1995;8(1):18–22.
  • Pomey M, Ghadiri D, Karazivan P, et al. Patients as partners: a qualitative study of patients' engagement in their health care. PloS One. 2015;10(4):e0122499.
  • Bowers NL, Merrell GA, Foster T, et al. Does use of a night extension orthosis improve outcomes in patients with dupuytren contracture treated with injectable collagenase? Journal of Hans Surgery Global Online. 2021;3(5):272–277.
  • Karam M, Kahlar N, Abul A, et al. Comparison of hand therapy with or without splinting postfasciectomy for dupuytren’s contracture: systematic review and Meta-analysis. J Hand Microsurg. 2021. DOI:10.1055/s-0041-1725221.
  • Andersson V, Otterstrom-Rydberg E, Karlsson A. The importance of written and verbal information on pain treatment for patients undergoing surgical interventions. Pain Manag Nurs. 2015;16(5):634–641.
  • Dahlin LB, Bainbridge C, Leclercq C, et al. Dupuytren’s disease presentation, referral pathways and resource utilisation in Europe: regional analysis of a surgeon survey and patient chart review. Int J Clin Pract. 2013;67(3):261–270.